Related Tags >> Deals Phase II milestones Merger

pharmaceutical company News

Most Popular pharmaceutical company Story

Genzyme on buyouts: Thanks but no thanks

December 6, 2007 — 7:59am ET

We're happy the way we are, thank you very much. That's what Genzyme CEO Henri Termeer (photo) has to say to rumors that the... Read more...

Latest Headlines

Italy's Creabilis garners €20M in Series A
June 5, 2008
Critical Therapeutics, Cornerstone to merge
May 2, 2008
Pfizer inks $25M research deal
January 25, 2008
Genzyme on buyouts: Thanks but no thanks
December 6, 2007
Press Release: Biogen Idec and Cardiokine Partner to Develop Lixivaptan, a Novel Vasopressin Antagonist
July 2, 2007
Press Release: Anacor Pharmaceuticals Says Schering-Plough Corporation To Develop Its Anti-Fungal Drug
February 2, 2007
Anacor forges $625M pact with Schering-Plough
February 1, 2007
Press Release: Affymax Receives $10 Million Milestone Payment
February 1, 2007
Press Release: Affymax Receives $10 Million Milestone Payment
February 1, 2007
Press Release: Safety Monitoring Board Recommends Continuation of EntreMed's MKC-1 Phase 2 Breast Cancer Study
January 23, 2007
Vectura inks U.S. development deal for asthma therapy
December 20, 2006
Press Release: Pozen Expects to Submit Revised Response to Trexima Approvable Letter by Year End
December 12, 2006
Press Release: Barr's Subsidiary PLIVA Receives Approval for Pravastatin Tablets
November 27, 2006
Press Release: Mayne Pharma Acquires Remaining Nipent Rights
November 26, 2006
Press Release: Teva Announces Agreement With Pfizer
November 21, 2006
Press Release: Ambrilia Biopharma Announces European Licensing Partnership With TEVA
November 14, 2006
Press Release: MediQuest Therapeutics announces Vascana Phase 3a clinical trial results
November 10, 2006
Valentis to merge with Urigen
October 5, 2006
Start-up pockets $39M, licenses new biologic
September 5, 2006
Predix signs off on $307.5M licensing deal
July 30, 2006

Paid Research Reports